PDCD1 and neoplasm: Since PD-1 and IL-12 receptors are both highly expressed on intratumoral CD8+T cells, especially tumor-reactive T cells, it is worth exploring whether αPD-1 antibodies would help to restore the attenuated bioactivity of IL-12 on effector cells.